In contrast, some cancers, such as H3.3-G34R gliomas, may have enhanced susceptibility to DNA damage leading to the accumulation of extrachromosomal DNA and thereby increased sensitivity to STING agonists (27). This evidence concerns the gene STING1 and cancer.